siRNA therapy lowers triglycerides in patients along with rare health condition

.INVESTIGATION HIGHLIGHT.19 September 2024.

Plozasiran decreased triglyceride degrees through 80% and also lowered the risk of pancreatitis in patients with persistent chylomicronemia, with or without a hereditary diagnosis.